DANIEL
MORALES CANO
Profesor ayudante doctor
Aarhus University
Århus, DinamarcaPublicaciones en colaboración con investigadores/as de Aarhus University (7)
2024
-
Cholesterol lowering depletes atherosclerotic lesions of smooth muscle cell-derived fibromyocytes and chondromyocytes
Nature Cardiovascular Research, Vol. 3, Núm. 2, pp. 203-220
2023
-
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)
Frontiers in Pharmacology
-
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
Frontiers in Pharmacology, Vol. 14
-
Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension
American Journal of Respiratory Cell and Molecular Biology, Vol. 69, Núm. 2, pp. 147-158
-
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities
PLoS pathogens, Vol. 19, Núm. 1, pp. e1011063
-
Topography of immune cell infiltration in different stages of coronary atherosclerosis revealed by multiplex immunohistochemistry
IJC Heart and Vasculature, Vol. 44
2021
-
Fibrous Caps in Atherosclerosis Form by Notch-Dependent Mechanisms Common to Arterial Media Development
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 41, Núm. 9, pp. E427-E439